The Tendon That Refused to Heal
Daniel was 38 when his Achilles finally quit on him. Not dramatically — no pop, no sudden tear. Just a slow, grinding rebellion that built over eighteen months until walking down stairs became the worst part of the morning. He’d tried rest. Tried ice. Tried the anti-inflammatory protocol his GP suggested. Nothing worked for more than a few days at a stretch. The pain always came back, usually worse after the rest period than before it.
His sports medicine doctor eventually walked him through what was actually happening in that tendon: not inflammation, not a tear, but something called tendinopathy — a degenerative condition where the tendon tissue loses its organized structure and starts failing at the cellular level. The treatment was counterintuitive enough that Daniel nearly walked out of the office. To fix the damaged tendon, the doctor wanted him to load it — specifically, exercises putting the Achilles under significant eccentric stress, repeatedly, every day, for twelve weeks.
“You want me to do heel drops when standing on my heels hurts?” Daniel asked.
Sounds like medical sadism until the biology is understood. And once the biology is understood, the Alfredson protocol — 180 eccentric heel drops per day, six days a week, minimum twelve weeks — turns out to be not just comprehensible but almost elegant. It’s one of the few physical therapy protocols that’s genuinely evidence-based, specifically designed, and rigorously tested in clinical trials. For chronic Achilles tendinopathy that’s failed conservative treatment, it has an extraordinary success rate.
What Is Achilles Tendinopathy — And Why Most People Get It Wrong
The Achilles tendon is the largest and strongest tendon in the body. It connects the calf muscles — gastrocnemius and soleus — to the heel bone (calcaneus), transmitting the enormous forces generated during walking, running, jumping. During running, it experiences loads of 6-12 times body weight with each stride. For a 70kg runner, that’s 420-840 kilograms of force through the tendon, hundreds or thousands of times per run.
Achilles tendinopathy affects approximately 9-10% of recreational runners and 24-45% of competitive runners at some point in their careers. Common in non-runners too — middle-aged adults who are sedentary or intermittently active, particularly after sudden increases in activity level. The classic presentation is pain and stiffness in the Achilles tendon area, typically 2-6 centimeters above the insertion on the heel (midportion tendinopathy) or at the insertion itself (insertional tendinopathy).
The critical misunderstanding — the one that leads to years of ineffective treatment — is calling this “tendinitis.” The suffix “-itis” means inflammation. For decades, Achilles tendon pain got treated as inflammatory: rest, ice, anti-inflammatory medications (NSAIDs), corticosteroid injections. Sometimes temporary relief, rarely lasting cure, because chronic Achilles tendon pain isn’t primarily an inflammatory condition.
Histological studies — microscopic examination of biopsied tendon tissue — have been consistently revealing here. Purdam et al. (2004), and multiple subsequent researchers, found chronic symptomatic tendons show remarkably little inflammatory infiltrate. Instead they show what’s called a failed healing response: disorganized collagen structure, increased ground substance (the gel-like material filling connective tissue), abnormal cell proliferation (increased tenocyte density with rounded rather than spindle-shaped cells), and neovascularization — new blood vessel growth accompanied by nerve ingrowth, explaining why the condition hurts. This histological pattern is tendinosis, not tendinitis. The “osis” suffix matters because it flips the entire treatment paradigm.
Rest makes tendinosis worse over time, not better. Tendon tissue depends on mechanical loading to maintain its structural integrity. The collagen fibers giving tendons their tensile strength are organized in parallel bundles aligned along the line of stress — an arrangement actively maintained by mechanical loading and remodeling. Remove the loading, and tenocytes receive no mechanical signal, collagen production drops, existing collagen degrades faster, and the disorganized pathological tissue just persists. Rest is temporary symptom management, not healing.
Corticosteroid injections, widely used for decades, have particularly poor evidence in tendinopathy. They provide short-term pain relief (2-4 weeks), but multiple randomized trials show no long-term benefit versus placebo, and possibly worse outcomes through tendon weakening. A 2010 Cochrane review by Coombes et al. on corticosteroid injections for tendinopathy found short-term benefits consistently didn’t hold at follow-up, with several studies showing inferior outcomes at 6 months compared to watchful waiting.
The Alfredson Protocol: The Study That Changed Everything
Hakan Alfredson is a Swedish orthopedic surgeon who, in the mid-1990s, was personally suffering from chronic Achilles tendinopathy. He couldn’t get the surgery he needed because his hospital wouldn’t approve it for a “non-disabling” condition. In what’s become one of sports medicine’s more unusual stories, he designed an experiment to deliberately rupture his own tendon so surgery would become unavoidable. The experiment failed — instead of rupturing, his tendon healed.
What Alfredson was doing: high-load eccentric heel drops — standing on the edge of a step on the affected foot, raising up on both feet, then lowering slowly (concentrically up on two feet, eccentrically down on one). The pain, significant at first, gradually decreased over weeks. His tendon remodeled.
That personal experiment led to Alfredson’s landmark 1998 paper in the American Journal of Sports Medicine: “Heavy-Load Eccentric Calf Muscle Training for the Treatment of Chronic Achilles Tendinosis.” The study enrolled 15 patients with chronic Achilles tendinosis who’d failed conservative treatment and were scheduled for surgery. They completed a 12-week eccentric training program — the Alfredson protocol. All 15 returned to their previous running levels. The control group — 15 patients matched for severity, continuing conservative treatment — showed no improvement and proceeded to surgery. The result was dramatic enough to fundamentally change Achilles tendinopathy treatment guidelines internationally.
The protocol Alfredson developed and validated: 3 sets of 15 reps of eccentric heel drops, twice daily, six days a week, for 12 weeks. That’s 180 reps per day, 1,080 per week, roughly 13,000 over the course of treatment. Two versions: knee straight (targets gastrocnemius), knee bent (targets soleus). Pain during exercise was allowed — the original protocol actually specified training “into pain” as long as it stayed tolerable and didn’t exceed moderate intensity on a numerical scale.
Pain exceeding tolerance, or causing a significant limp, is the boundary.
The Biomechanical Rationale: Why Eccentric Loading Works
The effectiveness of eccentric loading for tendinopathy isn’t fully understood mechanistically, but the leading hypotheses are well-supported by subsequent research and converge on a consistent picture.
Mechanical stimulation of tenocytes. Tendon cells respond to mechanical loading by producing collagen and other extracellular matrix proteins. Eccentric loading produces unique mechanical stimuli that appear particularly effective at driving organized collagen production. Langberg et al. (2007) used microdialysis to measure collagen synthesis markers in the Achilles tendon during eccentric training and found significantly increased collagen synthesis activity during and after the protocol — direct evidence for the proposed mechanism.
Disruption of neovascularization. The new blood vessels — and accompanying nerves — that grow into pathological tendon tissue are a primary pain source in tendinopathy. These vessels are fragile, sensitive to mechanical disruption. Eccentric loading has been hypothesized to mechanically disrupt these neovascular ingrowths, reducing pain signaling from the tendon. Alfredson et al. (2003) used Doppler ultrasound to demonstrate that eccentric training reduced neovascularization in treated tendons — and crucially, pain reduction correlated with the degree of neovascularization reduction.
Force lengthening and tendon stiffness modification. Eccentric contractions happen while the muscle-tendon unit is being lengthened, producing high tendon loads at longer muscle lengths than concentric contractions do. This loading pattern may specifically stimulate remodeling of pathological tendon tissue — the disorganized, cross-linked collagen characterizing tendinosis may be preferentially stressed and disrupted by eccentric loading, allowing replacement with organized healthy tissue.
Neurological desensitization. There’s also a neuroplasticity component to tendinopathy. The nervous system becomes sensitized to pain signals from the tendon over time — central pain processing amplifies. The “train into pain” aspect of the Alfredson protocol may desensitize these pain pathways through graded exposure, a well-established principle in chronic pain management, though typically applied more cautiously elsewhere.
The distinction between midportion and insertional tendinopathy matters for how the eccentric protocol gets applied. The original Alfredson protocol — heel drops off a step — increases Achilles tendon load by taking the calcaneus below step level, increasing tendon lengthening. Works well for midportion tendinopathy (2-6cm above the insertion). For insertional tendinopathy — at the heel bone itself — dropping the heel below step level compresses the tendon against the posterior calcaneal prominence (Haglund’s deformity), which typically worsens insertional symptoms. For insertional Achilles tendinopathy, the protocol needs modification: eccentric drops on a flat surface only, not below step level, possibly supplemented with heavy slow resistance training.
The Evidence Base Since Alfredson 1998
The 1998 study was a case series, not a randomized controlled trial. Subsequent research has both replicated and refined the findings with more rigorous methodology.
Roos et al. (2004) ran a randomized trial in 44 patients comparing eccentric training, concentric training, and a night splint. At 12 weeks, the eccentric group showed significantly greater pain reduction and patient satisfaction than the other groups — establishing that the eccentric component itself, not just loading in general, was the critical element.
Mafi et al. (2001) randomized 45 patients to either the Alfredson eccentric protocol or a concentric training protocol matched for volume and intensity. At 12 weeks, 82% of the eccentric group rated their condition better or much better, compared to 36% of the concentric group. An important study, directly comparing eccentric to concentric loading and showing that contraction type — not just loading itself — mattered.
A 2012 Cochrane review on eccentric exercises for Achilles tendinopathy (Woodley et al.) found moderate-quality evidence supporting eccentric exercise for midportion tendinopathy, with 10 of 11 included studies favoring eccentric exercise over comparator treatments. The review noted evidence for insertional tendinopathy was weaker.
More recent research has challenged whether eccentric specificity is actually the critical variable. Beyer et al. (2015) compared the Alfredson eccentric protocol to heavy slow resistance training — a different loading strategy — in 58 patients with chronic midportion tendinopathy. Both groups improved significantly at 12 weeks, and heavy slow resistance training produced comparable outcomes with better patient satisfaction and adherence. Suggests high-load mechanical stimulation to the tendon is the key element, with eccentric-versus-concentric-versus-isometric specificity being of secondary importance.
Isometric loading has attracted recent research attention. Rio et al. (2015) demonstrated isometric exercises — sustained contraction without movement — at high loads produced significant immediate pain reduction in patellar tendinopathy, and subsequent research has explored this for Achilles tendinopathy too. Isometric contractions may be particularly useful in the early, most acute phases when eccentric loading is too painful, or for insertional tendinopathy where eccentric drops cause problems.
The Achilles Rehabilitation Protocol Framework
Based on the Alfredson research, subsequent refinements, and current clinical consensus, here’s The Achilles Rehabilitation Protocol — a structured framework for addressing chronic midportion Achilles tendinopathy through progressive loading.
- Phase 1 — Isometric Loading (Weeks 1-2): Before starting full eccentric heel drops, begin with isometric calf raises held for 45-second intervals, 5 reps, twice daily. Stand on a flat surface, rise onto the balls of both feet, shift weight to the affected leg, hold. This provides mechanical stimulation without the eccentric lengthening stress that may be too intense initially. Isometric loading also has direct analgesic effects, helping desensitize the pain pathway before progressing.
- Phase 2 — Eccentric Protocol Initiation (Weeks 2-6): Begin the Alfredson protocol. Using a step or stair edge: rise on both feet, shift weight to the affected foot, lower slowly over 3-4 seconds until the heel drops below step level (midportion only; flat surface only for insertional). Keep the knee straight for sets 1-3 (gastrocnemius focus), bent approximately 30 degrees for sets 4-6 (soleus focus). 3 sets of 15 reps each, twice daily. Pain exceeding 5/10 on a numerical scale, or causing significant limping, means reducing range of motion and progressing more gradually. Progress each week by increasing range of motion and slightly increasing eccentric phase speed.
- Phase 3 — Load Intensification (Weeks 6-10): Once 3×15 twice daily is achievable with pain no greater than 3/10, add resistance. Weighted backpack starting at 5-10% body weight, progressing weekly. Alternatively, a calf raise machine at the gym for the weighted eccentric portion. Maintain the 3-second eccentric lowering tempo. This phase directly addresses the need for progressive overload in tendon remodeling — tendons adapt to loads they experience, not loads that feel comfortable.
- Phase 4 — Heavy Slow Resistance (Weeks 8-12+): Incorporate bilateral and unilateral calf raises with heavier loads on a flat surface, full range of motion, slow tempo — 3 seconds up, 3 seconds down. Progress to loads where 3×8-12 reps is genuinely challenging. This phase develops both concentric and eccentric strength and mirrors normal gait loading patterns more closely than isolated eccentric drops.
- Phase 5 — Functional Loading (Weeks 10-16): Add plyometric progressions: double-leg jump and land, then single-leg hop and land, then walking, then running on flat surfaces. Progress running volume no more than 10% per week. The tendon needs to experience running’s high loads to fully adapt, but the progression has to stay gradual to avoid reloading symptoms.
- Ongoing Maintenance: Once symptoms have resolved and full function is restored, continue eccentric calf exercises 2-3 times per week indefinitely as maintenance. Achilles tendinopathy has a high recurrence rate when loading is abandoned completely. Progressive loading throughout a training career — not just during rehab — is the long-term solution.
“The tendon does not heal with rest. It heals with load — the right load, applied progressively, consistently enough to drive structural remodeling. The discomfort during the Alfredson protocol is not injury; it is the necessary stimulus for adaptation. The distinction between helpful pain and harmful pain is one of the most important clinical judgments in tendinopathy management.” — Synthesis of Alfredson 1998 and Beyer 2015 evidence
Nutritional Support for Tendon Healing
The rehabilitation protocol is the primary intervention for Achilles tendinopathy, but nutritional factors meaningfully influence tendon healing capacity and deserve a place in any comprehensive management plan.
Collagen synthesis — the primary goal of tendon remodeling — requires specific nutritional substrates. Glycine, proline, hydroxyproline, and hydroxylysine dominate tendon collagen’s amino acid makeup. Vitamin C is an essential cofactor for prolyl and lysyl hydroxylase, the enzymes converting proline and lysine into the hydroxylated forms required for stable collagen triple helix formation. Shaw et al. (2017) demonstrated in an elegant study that consuming 15g of hydrolyzed collagen with 225mg vitamin C 60 minutes before exercise significantly increased amino acid availability and collagen synthesis markers versus placebo. The timing — 60 minutes before loading — matters: it provides amino acid substrates right when mechanical stimulation is driving collagen synthesis most strongly.
Vitamin C on its own has documented roles in tendon health. Deficiency produces scurvy, which includes tendon pathology. Supplementation at physiological doses (200-500mg/day, not megadoses) is reasonable support. Foods rich in vitamin C — citrus fruits, bell peppers, berries, kiwi — remain the preferred source, with supplementation as backup.
Omega-3 fatty acids (EPA and DHA) modulate tendon inflammation and may support healing through several mechanisms. Chronic tendinopathy isn’t primarily inflammatory, but acute exacerbations and early-stage loading responses do involve inflammatory signaling omega-3s can productively modulate. Cell membrane incorporation of EPA and DHA shifts the eicosanoid profile toward less pro-inflammatory mediators. 2-3g/day of combined EPA+DHA from fish oil is a reasonable supplementation target.
Protein intake adequacy matters broadly for collagen synthesis. Total daily protein at 1.6g/kg bodyweight or above supports the continuous collagen remodeling that tendon rehabilitation requires. Athletes undershooting protein intake — common during periods when injury reduces appetite or motivation for nutrition discipline — may see slower tendon healing as a result.
Blood glucose management matters too, because elevated blood glucose directly glycates collagen — attaches glucose molecules to collagen fibers through non-enzymatic browning reactions, a process called Advanced Glycation End-product (AGE) formation. Glycated collagen is stiffer, less elastic, more prone to damage. Part of why type 2 diabetes is associated with increased tendinopathy risk. Minimizing glycemic spikes through food choices and meal timing supports tendon structural quality.
Pain During the Protocol: What’s Acceptable and What’s Not
The “train into pain” instruction in the original Alfredson protocol was deliberately controversial — it challenged the dominant “if it hurts, stop” paradigm in injury rehabilitation. Understanding the boundaries of acceptable pain is essential for using the protocol safely and effectively.
The traffic light model from Silbernagel et al. (2010) provides a practical framework for managing training pain in tendinopathy rehab. Green light: pain during exercise at 3/10 or below on a numerical scale. Continue training at current level. Yellow light: pain at 4-5/10. Proceed with caution — hold current volume without increasing load, monitor closely for post-exercise changes. Red light: pain exceeding 5-6/10 during exercise, or pain persisting more than 24 hours afterward, or morning stiffness taking more than 20 minutes to resolve and getting worse compared to the previous week. Reduce load before proceeding.
The critical distinction is between the deep, diffuse tendon pain that’s expected and acceptable during eccentric loading, and sharp, point-specific pain that may indicate something else entirely — a partial tear, a bone stress reaction at the calcaneal insertion, referred pain from a different structure. Pain that doesn’t fit the expected distribution of Achilles tendinopathy — 2-6cm above the heel, diffuse, worsening with load and improving with warmup, better after activity, stiff in the morning — warrants a sports medicine physician visit before starting the protocol. Imaging (ultrasound or MRI) is warranted if there’s any concern about tendon integrity or differential diagnosis.
The morning stiffness criterion is clinically useful for monitoring progress. Classic tendinopathy produces significant morning stiffness that usually resolves within 5-20 minutes of activity. As the tendon remodels and improves through the protocol, morning stiffness is typically the first symptom to improve — often a reliable early indicator the protocol is working, before pain levels visibly change. Tracking morning stiffness duration weekly provides an objective measure of progress independent of training session pain.
Common Mistakes That Derail Recovery
The Alfredson protocol has an impressive evidence base, but clinical success rates in real-world settings don’t always match the 90%+ reported in controlled trials. The gap between trial outcomes and real-world outcomes is largely explained by execution errors — predictable mistakes that undermine the protocol’s effectiveness.
Stopping too early is the most common mistake. Twelve weeks is the minimum duration cited in the original research, and many patients see little or no improvement in the first four to six weeks. Structural remodeling of tendon tissue takes time — collagen turnover in tendons is measured in months, not days. Patients who quit after six weeks because “it’s not working” have stopped precisely at the point when the tissue changes were beginning to accumulate. Commit to the full 12 weeks before evaluating.
Continuing to run at high volume while doing the protocol is another common failure mode. The eccentric protocol isn’t meant to be added on top of unmodified training — it replaces some training volume during the rehab phase. Running mileage should typically drop by 30-50% during the first 6-8 weeks of the protocol, then be gradually restored as symptoms improve. Adding the protocol on top of continued high training volume sends conflicting signals to the tendon — trying to heal while repeatedly reinjuring at the same time.
Insufficient load progression is a subtler but important error. The protocol is designed to progressively challenge the tendon, not to maintain comfortable loading indefinitely. Three months into the protocol, still doing the same bodyweight heel drops from the start and finding them entirely comfortable — that means the rehabilitation has stalled. Progressive overload is as necessary for tendon rehab as it is for strength development.
Ignoring the knee-bent variation is a common execution error. The original Alfredson protocol specifies both straight-knee and bent-knee (approximately 30 degrees) heel drops in each session. The straight-knee version primarily loads the gastrocnemius, the larger, more superficial calf muscle. The bent-knee version offloads the gastrocnemius and primarily loads the soleus, which has a different fiber type composition and different moment arm to the Achilles. The soleus contributes significantly to Achilles tendon loading, and soleus weakness is commonly implicated in chronic tendinopathy. Skipping the bent-knee variation leaves a meaningful portion of the treatment undone.
When the Protocol Fails: Next Steps
The Alfredson protocol has impressive success rates, but it doesn’t work for everyone. Approximately 10-30% of patients with chronic midportion Achilles tendinopathy don’t achieve satisfactory outcomes after completing a properly executed 12-week eccentric program. Several factors predict poorer response: insertional location (versus midportion), older age, longer symptom duration before starting treatment, obesity, systemic disease (particularly type 2 diabetes), and fluoroquinolone antibiotic use history (these antibiotics have direct toxic effects on tendon tissue).
For protocol non-responders, several evidence-supported second-line options exist. High-volume injections of saline or local anesthetic around the neovascular ingrowths, under ultrasound guidance, have shown benefit across multiple trials by mechanically disrupting the blood vessels and nerves producing pain while preserving the main tendon structure. Platelet-rich plasma (PRP) injections have generated significant research interest, with mixed trial results — the evidence for midportion tendinopathy is moderately positive, though methodological quality varies across studies. Extracorporeal shockwave therapy (ESWT) has moderate evidence for both midportion and insertional tendinopathy, particularly as a complement to the eccentric program. It appears to work through mechanisms similar to eccentric loading — mechanical disruption of neovascularization and stimulation of tendon cell activity.
Surgery is a last resort after 6-12 months of failed conservative management. Multiple surgical procedures exist, including percutaneous longitudinal tenotomy (small incisions disrupting neovascularization and stimulating a healing response), open debridement of pathological tissue, and various tendon augmentation procedures. Success rates are reasonable (70-85%), but recovery is prolonged — 6-12 months to full activity — and surgical outcomes aren’t universally superior to continued conservative care.
Prevention: Long-Term Achilles Tendinopathy Eccentric Strategy
Achilles tendinopathy is highly recurrent — studies report relapse rates of 30-60% within two years in athletes who return to full training. Prevention matters as much as treatment, and the same mechanical loading principles apply.
Calf strength maintenance is the foundation of prevention. Athletes maintaining regular eccentric calf training year-round show substantially lower rates of Achilles tendinopathy than those only addressing calf strength during rehab episodes. A maintenance protocol of 2-3 sessions weekly of calf raises — loaded bilateral and single-leg, through full range of motion — is a minimal investment against a condition that can sideline someone for months.
Training load management — particularly controlling the rate of increase in running mileage — is the primary modifiable risk factor for Achilles tendinopathy onset. The widely cited “10% rule” (don’t increase weekly running mileage by more than 10% per week) is an oversimplification, but it captures the right principle: tendons adapt more slowly than cardiovascular fitness, and spikes in training load overwhelm the tendon’s adaptation capacity. Gabbett et al.’s research on acute:chronic workload ratios offers a more sophisticated framework, but the practical point holds — ramp training up gradually.
Footwear transition management matters for runners. Transitioning from traditional heel-drop running shoes (8-12mm heel-to-toe drop) to minimalist or zero-drop footwear dramatically changes Achilles tendon loading. The lower drop requires the calf-Achilles complex to absorb more of the impact energy previously handled by the shoe’s cushioning. Done rapidly, this transition frequently produces Achilles tendinopathy. Done over 6-12 months with concurrent calf strengthening, it can be accomplished safely and may reduce long-term tendon stress.
Achilles Tendinopathy Eccentric Q&A
Q: How long does it take for the Alfredson protocol to work?
A: The original 1998 study used 12 weeks as the treatment duration, and most clinical research aligns on this as a minimum. Many patients see little or no improvement in the first 4-6 weeks — normal, expected. Structural remodeling of tendon tissue is slow; collagen turnover happens over months. Commit to the full 12 weeks before evaluating results. Some patients need 16-20 weeks for complete resolution, particularly with longer symptom duration before starting treatment.
Q: Should I stop running completely during the Alfredson protocol?
A: Complete rest is counterproductive for tendon healing and unnecessary in most cases. A typical approach reduces running volume by 30-50% during the first 6-8 weeks of the protocol, maintaining enough loading to signal adaptation without overloading the remodeling tissue. As morning stiffness and post-exercise pain decrease, running volume can be gradually restored. Complete cessation of activity for weeks is the approach most likely to produce deconditioning without meaningful tendon benefit.
Q: Is the Alfredson protocol the same for insertional Achilles tendinopathy?
A: No — the protocol needs modification for insertional tendinopathy. The original eccentric heel drops off a step, with the heel descending below step level, compress the tendon against the back of the heel bone, worsening insertional symptoms. For insertional tendinopathy, eccentric drops should stay on a flat surface only, not below neutral. Some research supports heavy slow resistance training as an alternative for insertional tendinopathy — potentially better tolerated and similarly effective.
Q: I’ve had Achilles pain for only 2-3 weeks. Should I start the Alfredson protocol?
A: The Alfredson protocol was designed for chronic tendinopathy that’s failed conservative treatment — symptoms of at least 3-6 months duration. For acute Achilles pain of 2-3 weeks, a more conservative initial approach is appropriate: temporarily reduce training volume, address obvious contributing factors (sudden mileage increase, footwear change, calf weakness), begin light calf loading, monitor closely. See a sports medicine physician for proper diagnosis — acute Achilles pain should be assessed for a tendon tear, which is a different injury requiring different management.
Q: Can I do the protocol if I have Achilles tendinopathy in both legs?
A: Yes, both sides can be treated simultaneously with the protocol. This actually simplifies execution — use both legs for the concentric (rising) phase and single leg for the eccentric (lowering) phase on each side alternately, or complete all reps for one side before switching. Total session time runs longer, but the protocol applies fully bilaterally.
Q: When do I add weight to the heel drops, and how much?
A: The original Alfredson protocol specified adding weight once the prescribed 3×15 twice daily could be performed with pain no greater than 3-4/10. Start with a loaded backpack at 5-10% of body weight, increasing by 5% weekly as tolerated. At the gym, calf raise machines allow more precise loading. The weight should make 3×15 challenging but achievable within the pain boundaries. Some patients respond well to adding weight earlier — weeks 4-6 — while others need more time before adding external load.
Q: Why do corticosteroid injections feel good initially but not long-term?
A: Corticosteroids have potent anti-inflammatory and analgesic effects, providing genuine short-term relief. The problem is that chronic Achilles tendinopathy isn’t primarily driven by inflammation — it’s a failed healing/degenerative process. The steroid addresses the symptom (some inflammatory signaling and pain) but not the underlying pathology (disorganized collagen, neovascularization, failed healing response). Corticosteroids can also directly weaken tendon tissue through effects on collagen synthesis. Which is why multiple clinical evidence points to worse 6-12 month outcomes for corticosteroid injection compared to other approaches, despite better 4-6 week outcomes.
What Imaging Tells You (And What It Doesn’t)
Ultrasound and MRI are the two primary imaging modalities for Achilles tendinopathy assessment. Understanding what these images show — and importantly, what they don’t tell you — prevents both under-treatment (dismissing significant pathology) and over-treatment (pursuing surgical intervention based on imaging alone).
Ultrasound is the most practical, cost-effective first-line imaging tool. In skilled hands it identifies tendon thickening (normal Achilles tendon diameter at the midportion runs approximately 4-6mm; chronic tendinopathy typically shows 8-12mm or more), hypoechoic areas indicating regions of collagen disorganization, neovascularization detectable on Doppler (color Doppler shows new blood vessel ingrowth — a hallmark of tendinopathy), tendon tears (focal discontinuity of fiber alignment), and calcifications (particularly relevant for insertional tendinopathy). It’s dynamic — the examiner can assess tendon movement during active and passive loading in real time — an advantage over static MRI.
MRI provides more complete soft tissue characterization but is substantially more expensive and less available for routine musculoskeletal assessment. On MRI, tendinopathy appears as increased signal intensity within the tendon on T1 and T2 weighted sequences, representing regions of collagen fiber disruption and increased water content. Partial tears appear as focal T2 signal abnormalities; complete tears appear as disruption of tendon continuity. MRI is particularly useful for characterizing insertional tendinopathy with Haglund’s deformity and for identifying retrocalcaneal bursitis, which can coexist with and complicate Achilles tendinopathy.
The critical caveat about imaging: findings don’t reliably predict symptoms, and symptoms don’t reliably predict imaging severity. Multiple studies have found significant tendon structural abnormalities on ultrasound and MRI in completely asymptomatic individuals — particularly athletes who’ve trained hard for years. Conversely, some patients with severe functional limitation from Achilles tendinopathy show relatively modest imaging findings. Cook and Purdam’s continuum model of tendinopathy helps explain this: imaging findings represent the structural state of the tendon, but symptoms represent the interaction between that structural state, load, and neural sensitization — partially independent variables.
The practical implication: don’t let imaging findings drive treatment decisions alone. A structural abnormality on ultrasound without symptoms doesn’t need treatment. Significant symptoms with mild imaging findings need the same rehabilitation protocol as severe imaging findings. And “normal” imaging after successful rehabilitation doesn’t mean tendon structure has been fully restored — the tendon may remain structurally abnormal while being functionally asymptomatic and fully capable of athletic demands. Follow the symptoms and functional capacity, not the images.
Long-Term Outlook and Returning to Athletics
Daniel, from the opening of this piece, completed his twelve weeks of the Alfredson protocol with considerably more diligence than his initial skepticism suggested he would. By week eight, morning stiffness had dropped from fifteen minutes to under two. By week twelve, he could walk down stairs without a strategy. By week sixteen — after adding a gradual return-to-running protocol — he was back to pre-injury mileage without pain.
Two years later, he still does three sets of single-leg calf raises three times a week, folded into his warm-up routine. No recurrence. That’s not coincidental — it’s the direct application of the biology. Tendons maintained under consistent, progressive mechanical load are substantially more resilient than tendons that only get loaded when competing or running and never during dedicated strengthening work.
Long-term outcome data for Achilles tendinopathy treated with the Alfredson protocol is generally favorable, though not universally so. Alfredson’s own 10-year follow-up of his original case series found most patients maintained good outcomes, able to run and complete athletic activities. A meaningful minority — 15-25% — reported some residual symptoms or needed additional treatment. Predictors of worse long-term outcomes: delaying treatment more than 12-18 months from symptom onset, older age at treatment initiation, insertional location, and failure to maintain any loading program after initial rehab.
The evidence-based answer for anyone dealing with chronic Achilles tendinopathy: this is a manageable condition with a high success rate using a simple, equipment-minimal treatment protocol. The hardest part isn’t the physical execution of 180 heel drops a day — it’s the psychological discipline to keep going when the initial weeks show nothing, to resist the temptation to rest completely, and to resist the temptation to dramatically ramp up training load the moment symptoms start improving. Patience and consistency are the non-negotiable requirements. The biology works. The job is applying it.
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map